SynopsisAtrial septal defect (ASD) is one of the most common congenital heart defects requiring procedural intervention. ASD closure devices are intended to close openings between the atria (the two upper chambers of the heart). It can be used to treat patients with c.....
SynopsisThe global Abdominal Aorta Stent Graft System market was valued at US$ 3202.6 million in 2023 and is anticipated to reach US$ 4006.9 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030. North American market for Abdominal Aort.....
SynopsisDiabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). The global Diabetic Retinopathy Treatment mark.....
SynopsisImplantable Blood Glucose Monitor is implanted subcutaneously into the upper arm under local anesthesia, the system allows for replacement of finger stick blood glucose measures. The global Implantable Blood Glucose Monitor market was valued at US$ 39 mi.....
SynopsisSpecial lamp that assist medical personnel during a surgical procedure. The global Surgical Shadowless Lamp market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2.....
SynopsisPalonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). The global Palonosetron market was valued at US$ 113 million in 2023 and is anticipated to reach US$ 147.6.....
SynopsisDiagnostic fluoroscopy describes a number of exams that utilize live X-ray to diagnose certain conditions, diseases, or to visualize moving structures. The global Diagnostic Fluoroscopy Systems market was valued at US$ million in 2023 and is anticipated .....
SynopsisThe global Alzheimer’s Agitation Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022.....
Synopsis Drugs for the treatment of primary immunodeficiency diseases Highlights The global Primary Immunodeficiency Drugs market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of.....
SynopsisThe global Bilirubin Assay Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Bilirubin Assay Kits is estimated to increase.....
